These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11959366)
1. Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia. Zhang XY; Zhou DF; Yuan CL; Zhang PY; Wu GY; Shen YC Psychiatry Res; 2002 Apr; 109(3):297-302. PubMed ID: 11959366 [TBL] [Abstract][Full Text] [Related]
2. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study. Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996 [TBL] [Abstract][Full Text] [Related]
3. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone. Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271 [TBL] [Abstract][Full Text] [Related]
4. Fasting insulin serum levels and psychopathology profiles in male schizophrenic inpatients treated with olanzapine or risperidone. Konarzewska B; Waszkiewicz N; Galińska B; Szulc A Neuro Endocrinol Lett; 2013; 34(4):322-8. PubMed ID: 23803867 [TBL] [Abstract][Full Text] [Related]
5. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia. Charan A; Shewade DG; Rajkumar RP; Chandrasekaran A Psychiatry Res; 2016 Jun; 240():209-213. PubMed ID: 27111215 [TBL] [Abstract][Full Text] [Related]
6. The effect of risperidone treatment on superoxide dismutase in schizophrenia. Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC J Clin Psychopharmacol; 2003 Apr; 23(2):128-31. PubMed ID: 12640213 [TBL] [Abstract][Full Text] [Related]
7. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC J Clin Psychiatry; 2004 Jul; 65(7):940-7. PubMed ID: 15291683 [TBL] [Abstract][Full Text] [Related]
8. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566 [TBL] [Abstract][Full Text] [Related]
9. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Konarzewska B; Wołczyński S; Szulc A; Galińska B; Popławska R; Waszkiewicz N Psychoneuroendocrinology; 2009 Jan; 34(1):129-39. PubMed ID: 18838228 [TBL] [Abstract][Full Text] [Related]
11. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group. Chouinard G; Kopala L; Labelle A; Beauclair L; Johnson SV; Singh KI Can J Psychiatry; 1998 Dec; 43(10):1018-25. PubMed ID: 9868567 [TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone. Markianos M; Hatzimanolis J; Lykouras L Psychiatry Res; 1999 Dec; 89(2):115-22. PubMed ID: 10646830 [TBL] [Abstract][Full Text] [Related]
13. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Kinon BJ; Gilmore JA; Liu H; Halbreich UM Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681 [TBL] [Abstract][Full Text] [Related]
16. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group. Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995 [TBL] [Abstract][Full Text] [Related]
17. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia. Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206 [TBL] [Abstract][Full Text] [Related]
18. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study. Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348 [TBL] [Abstract][Full Text] [Related]
19. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine. Nakonezny PA; Byerly MJ; Rush AJ J Sex Marital Ther; 2007; 33(3):203-16. PubMed ID: 17454518 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics. Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]